FDMT vs GD · rev $37.0K vs P/E 22, rev $52.55B
4D Molecular Therapeutics Inc (FDMT) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
FDMT currently screens at market cap $518.1M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the FDMT and GD stock pages for the full models.
Not investment advice.